Plan your 2025 conference schedule better with LARVOL. Here is our list of the Top 25 Oncology Conferences worldwide. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData

Early detection saves lives! Low-dose CT scans are quick, painless and can make all the difference. Learn more about #lungcancer screening eligibility at: LUNGFORCE.org

Always amazing to learn from brilliant Regina Barragan-Carrillo 👏✨ #AI in Advanced #ProstateCancer OncoAlert MEDTRACK Gil Morgan Dra. María Natalia Gandur Quiroga Jose Fernando Moura, PhD Dr Joseph McCollom DO Deniz Can Guven Biagio Ricciuti, MD PhD Elisa Agostinetto Yakup Ergün Emre Yekedüz Eric K. Singhi, MD Elisa Agostinetto

Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: a systematic review and network meta-analysis buff.ly/d3rzvjA Systematic review and network meta-analysis of 28 randomized trials

Top Cancer Institutes on X in Q3 2025, based on oncologists' posts and views. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #CancerCare #OncologyUpdates

✅✅ A reminder by Dr. Rahaf Ajaj: She wasn’t on the Stanford list… but she made it to the Nobel stage. 🏅 Mary E. Brunkow, one of this year’s Nobel Prize winners in Medicine, has only 34 published papers and an H-index of 21. She never appeared in Stanford’s ranking of the

The OncoAlert #GUCancer Faculty, led by Dr. Natalia Gandur🇦🇷 , Dr. Regina Barragan🇲🇽 & Dr. Gil Morgan🇺🇸 have selected the OncoAlert TOP🔟 #ESMO25 Abstracts In #ProstateCancer, #KidneyCancer #BladderCancer and #PenisCancer to be presented in Berlin🇩🇪 Picked using a Delphi System

🇧🇷 774 women st I–III ER+ breast cancer(2021-2024): 55% treated in public 🏥 were younger, ⬆️premenopausal and dx later ⬆️time to Tx (93 vs 41 days). ⬇️access to ovarian suppress and ⬆️tamoxifen use. “Early-stage isn’t equal for everyone.” OncoAlert GBECAM

BREAKING NEWS The Norwegian Nobel Committee has decided to award the 2025 #NobelPeacePrize to Maria Corina Machado for her tireless work promoting democratic rights for the people of Venezuela and for her struggle to achieve a just and peaceful transition from dictatorship to

In the past year, #NobelPeacePrize laureate Maria Corina Machado has been forced to live in hiding. Despite serious threats against her life she has remained in the country, a choice that has inspired millions of people. When authoritarians seize power, it is crucial to

Week TOP in less than 5min is here 👇🏻 follow us for more OncoAlert

🎯 ITT vs TPP - the most misunderstood twins in clinical trials! Both look similar in papers… but they tell completely different stories. Let’s break it down the easy way 👇 1️⃣ ITT - Intention-To-Treat 🧠 “Once randomized, always analyzed.” Even if the patient skipped doses,

Temos anualmente um evento dedicado ao tema Sobre Bem Viver, porque além da sobrevida há a qualidade de vida que permite aos pacientes Viver Bem #cancerdemama

🔥 The #ESMO25 countdown is over — the stage is ours! From GI to Lung, GU to Breast — the OncoAlert team is ready to drop the most anticipated data in oncology 💣 LIVE from Berlin 🇩🇪 — where science meets energy ⚡️ 🌍 Follow the global dream team: #OncoAlertAF 🇺🇸

Revisando os subtipos moleculares do tumor de mama triplo negativo e pensando 💭 que ainda não selecionamos os pacientes de acordo com esse conhecimento para o tratamento #tnbc #bcsm

ASCENT-03 vs TB-02 Cross-over Chemo backbone … Biomarkers Waiting results to select better trial

NEWS FROM Industry: HER2CLIMB-05 Update Source: Pfizer announcement, report by Business wire buff.ly/27ChwaI Pfizer announced positive topline results from the Phase 3 HER2CLIMB-05 trial, which evaluated the addition of the tyrosine kinase inhibitor tucatinib to

Natalee X MONARCH-E OS vs PFS #ESMO25

Tag a friend or send the top 10 #ESMO25 ESMO - Eur. Oncology OncoAlert abstracts